Cardiac Surgery

Cardiac surgery is performed as an invasive open-heart procedure and includes coronary artery bypass graft (CABG) and heart valve surgery. Compared to less mature cardiovascular device markets, the cardiac surgery device market is relatively stable. Market growth will be driven primarily by the increasing prevalence of cardiovascular disease. Growth in the cardiac surgery market, particularly the CABG market, has been limited by the adoption of minimally invasive techniques, such as coronary angioplasty. The development of minimally invasive percutaneous heart valve therapy (PHVT) also threatens to limit the surgical heart valve market. MRG’s cardiac surgery device coverage includes on-pump CABG perfusion circuit devices, off-pump CABG devices, endoscopic vessel harvesting devices, anastomosis-assist devices, heart valves, PHVT devices, heart valve repair devices, and ventricular-assist devices. Our cardiac surgery device market report series is supported by extensive in-house industry expertise and market analytics.